OPKO HEALTH, INC. (OPK) Stock Profile — Insider Trades & Financials

Revenue$163.6M

Net Income-$8.4M

EPS$-0.08

Gross Margin48.9%

Market Cap$1.0B

Price Performance

Historical data including institutional events

Company Profile

Phillip Frost

CEO & Executive Director

OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".

Founded: 2006
Employees: 6,096
Headquarters: Miami, FL, United States
Website: opko.com

Peer ComparisonRevenue ($B)

▾

Loading company sections...

Feedback

Revenue$163.6M

Net Income-$8.4M

EPS$-0.08

Gross Margin48.9%

Market Cap$1.0B

Price Performance

Historical data including institutional events

Company Profile

Phillip Frost

CEO & Executive Director

OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".

Founded: 2006
Employees: 6,096
Headquarters: Miami, FL, United States
Website: opko.com

Peer ComparisonRevenue ($B)

▾

Cross-Section Event Timeline

INSIDERS · CONGRESS · EARNINGS

INSIDER BUYGary J. Nabel bought OPKJan 8, 2024

INSIDER BUYJane Ph D. Hsiao bought OPKJan 17, 2024

INSIDER BUYRichard M. Krasno bought OPKJan 29, 2024

INSIDER GRANT / AWARDSubbarao V. Uppaluri (Director) GRANT / AWARD OPKMar 18, 2026

INSIDER BUYJohn A. Paganelli bought OPKMar 20, 2026

INSIDER BUYJohn A. Paganelli (Director) BUY OPKMar 20, 2026

INSIDER GRANT / AWARDAlice Lin-Tsing Yu (Director) GRANT / AWARD OPKJun 18, 2026

INSIDER GRANT / AWARDSubbarao V. Uppaluri (Director) GRANT / AWARD OPKJun 18, 2026

INSIDER GRANT / AWARDRichard C. Pfenniger Jr. (Director) GRANT / AWARD OPKJun 18, 2026

INSIDER GRANT / AWARDJohn A. Paganelli (Director) GRANT / AWARD OPKJun 18, 2026

INSIDER GRANT / AWARDRoger Medel MD (Director) GRANT / AWARD OPKJun 18, 2026

INSIDER GRANT / AWARDPrem A. Lachman (Director) GRANT / AWARD OPKJun 18, 2026

INSIDER TAX WITHHOLDINGSteven D. Rubin (Executive VP-Administration) TAX WITHHOLDING OPKJul 24, 2026

INSIDER TAX WITHHOLDINGAdam Logal (Sr. Vice President, CFO) TAX WITHHOLDING OPKJul 24, 2026

⚡

Core Efficiency

ROE?

-0.71%

ROA?

-0.46%

D/E Ratio?

0.54

Op. Margin?

-4.26%

📊

Profitability Ratios

Net Margin?

-5.14%

Current Ratio?

3.35

Loading comparison...

Earnings Calendar

Filing history and next expected filing date

Next Expected Filing

Oct 31, 2026 (in 18 days)

Quarterly Report (10-Q) — Based on filing pattern

Oct 31, 2026

Predicted10-Q

Aug 28, 2026

10-Q/AQ2 202659d after period end

Aug 28, 2026

10-Q/AQ1 2026150d after period end

Feb 26, 2026

10-KQ4 202557d after period end

Feb 26, 2026

10-KFY 202557d after period end

Oct 29, 2025

10-QQ3 202512d after period end

Jul 31, 2025

10-QQ2 202510d after period end

May 1, 2025

10-QQ1 202516d after period end

Mar 3, 2025

10-KFY 202562d after period end

Data Freshness

Financial Data

1mo ago

Latest filing: 2026-07-27

SEC Metadata

1mo ago

Latest filing: 2026-08-28

Loading company sections...

Cross-Section Event Timeline

INSIDERS · CONGRESS · EARNINGS

INSIDER BUYGary J. Nabel bought OPKJan 8, 2024

INSIDER BUYJane Ph D. Hsiao bought OPKJan 17, 2024

INSIDER BUYRichard M. Krasno bought OPKJan 29, 2024

INSIDER GRANT / AWARDSubbarao V. Uppaluri (Director) GRANT / AWARD OPKMar 18, 2026

INSIDER BUYJohn A. Paganelli bought OPKMar 20, 2026

INSIDER BUYJohn A. Paganelli (Director) BUY OPKMar 20, 2026

INSIDER GRANT / AWARDAlice Lin-Tsing Yu (Director) GRANT / AWARD OPKJun 18, 2026

INSIDER GRANT / AWARDSubbarao V. Uppaluri (Director) GRANT / AWARD OPKJun 18, 2026

INSIDER GRANT / AWARDRichard C. Pfenniger Jr. (Director) GRANT / AWARD OPKJun 18, 2026

INSIDER GRANT / AWARDJohn A. Paganelli (Director) GRANT / AWARD OPKJun 18, 2026

INSIDER GRANT / AWARDRoger Medel MD (Director) GRANT / AWARD OPKJun 18, 2026

INSIDER GRANT / AWARDPrem A. Lachman (Director) GRANT / AWARD OPKJun 18, 2026

INSIDER TAX WITHHOLDINGSteven D. Rubin (Executive VP-Administration) TAX WITHHOLDING OPKJul 24, 2026

INSIDER TAX WITHHOLDINGAdam Logal (Sr. Vice President, CFO) TAX WITHHOLDING OPKJul 24, 2026

⚡

Core Efficiency

ROE?

-0.71%

ROA?

-0.46%

D/E Ratio?

0.54

Op. Margin?

-4.26%

📊

Profitability Ratios

Net Margin?

-5.14%

Current Ratio?

3.35

Loading comparison...

Earnings Calendar

Filing history and next expected filing date

Next Expected Filing

Oct 31, 2026 (in 18 days)

Quarterly Report (10-Q) — Based on filing pattern

Oct 31, 2026

Predicted10-Q

Aug 28, 2026

10-Q/AQ2 202659d after period end

Aug 28, 2026

10-Q/AQ1 2026150d after period end

Feb 26, 2026

10-KQ4 202557d after period end

Feb 26, 2026

10-KFY 202557d after period end

Oct 29, 2025

10-QQ3 202512d after period end

Jul 31, 2025

10-QQ2 202510d after period end

May 1, 2025

10-QQ1 202516d after period end

Mar 3, 2025

10-KFY 202562d after period end

Data Freshness

Financial Data

1mo ago

Latest filing: 2026-07-27

SEC Metadata

1mo ago

Latest filing: 2026-08-28

OPKO HEALTH, INC.

Price Performance

Company Profile

OPKO HEALTH, INC.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness

Recent Insider Trades

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness

Recent Insider Trades

OPKO HEALTH, INC.

Price Performance

Company Profile

The morning brief, before the bell.

OPKO HEALTH, INC.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness

Recent Insider Trades

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness

Recent Insider Trades